Close

Teva Pharma (TEVA) Receives First Paragraph IV Notice Related to COPAXONE (RDY)

August 7, 2014 12:07 PM EDT Send to a Friend
Teva Pharma (NYSE: TEVA) confirmed that it has received the first paragraph IV notice for its three-times-a-week COPAXONE 40 mg/mL ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login